CIK: 0001606074
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NGMUSD | Ngm Biopharmaceuticals INC | Stock-Other | 27.04% | -5.84% | +5.49% | |
| 2 | CNST | Constellation Pharmaceutical | Stock-Other | 24.08% | -5.21% | +0.69% | |
| 3 | RVMD | Revolution Medicines INC | Stock-Healthcare | 22.13% | +1.59% | — | |
| 4 | ✓ | Rapt Therapeutics INC | Stock-Other | 18.25% | -1.66% | — | |
| 5 | RCUS | Arcus Biosciences INC | Stock-Other | 6.22% | -3.66% | EXIT | |
| 6 | 2JQ | Gritstone Bio INC | Stock-Other | 2.29% | -0.75% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RCUS | Arcus Biosciences INC | +2% | — | Unchanged |
| 2 | 2JQ | Gritstone Bio INC | -1% | — | Unchanged |
| 3 | ✓ | Rapt Therapeutics INC | -4.1% | — | Unchanged |
| 4 | NGMUSD | Ngm Biopharmaceuticals INC | -9.2% | +5.49% | Add |
| 5 | CNST | Constellation Pharmaceutical | -9.7% | +0.69% | Add |
| 6 | RVMD | Revolution Medicines INC | — | NEW | New buy |